Trexquant Investment LP Genmab A/S Transaction History

Trexquant Investment LP

$8.01 Billion
Q1 2025

A detailed history of Trexquant Investment LP transactions in Genmab A/S stock. As of the latest transaction made, Trexquant Investment LP holds 467,185 shares of GMAB stock, worth $10.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

467,185

Previous 379,936 22.96%

Holding current value

$10.7 Million

Previous $7.93 Million 15.36%

% of portfolio

0.11%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$18.69 - $24.14 $1.63 Million - $2.11 Million	87,249 Added 22.96%	467,185 $9.15 Million
Q4 2024 Feb 12, 2025	BUY	$20.02 - $24.15 $6.33 Million - $7.63 Million	316,089 Added 495.07%	379,936 $7.93 Million
Q3 2024 Nov 12, 2024	BUY	$23.84 - $28.48 $1.25 Million - $1.49 Million	52,334 Added 454.56%	63,847 $1.56 Million
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $1.4 Million - $1.68 Million	-55,600 Reduced 82.85%	11,513 $289,000
Q1 2024 May 14, 2024	SELL	$26.43 - $32.77 $2.27 Million - $2.82 Million	-85,985 Reduced 56.16%	67,113 $2.01 Million
Q4 2023 Feb 09, 2024	BUY	$27.94 - $35.44 $4.28 Million - $5.43 Million	153,098 New	153,098 $4.87 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $2.66 Million - $3.3 Million	-76,312 Reduced 71.13%	30,974 $1.17 Million
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $3.23 Million - $4.5 Million	95,530 Added 812.61%	107,286 $4.55 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $370,549 - $4.39 Million	11,756 New	11,756 $378,000
Q2 2022 Aug 11, 2022	SELL	$26.83 - $38.57 $614,782 - $883,792	-22,914 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $768,024 - $984,659	-24,815 Reduced 51.99%	22,914 $829,000
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $1.71 Million - $2.25 Million	47,729 New	47,729 $1.89 Million
Q2 2021 Aug 12, 2021	SELL	$32.88 - $44.57 $225,359 - $305,482	-6,854 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$30.92 - $44.4 $211,925 - $304,317	6,854 New	6,854 $225,000
Q3 2020 Nov 06, 2020	SELL	$33.07 - $38.68 $736,601 - $861,558	-22,274 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$20.05 - $33.89 $61,172 - $103,398	3,051 Added 15.87%	22,274 $755,000
Q1 2020 May 08, 2020	BUY	$17.15 - $25.22 $329,674 - $484,804	19,223 New	19,223 $407,000

Others Institutions Holding GMAB

# of Institutions

248

Shares Held

66.2M

Call Options Held

729K

Put Options Held

398K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $15B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Genmab A/S Transaction History